High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: A KONSAR Program in 2004

Yonsei Medical Journal

Volumn 47, Issue 5, 2006, Pages 634-645

  Lee, Kyungwon ^a   Lim, Chang Hyun ^b   Cho, Ji Hyun ^c   Lee, Wee Gyo ^d   Uh, Young ^e   Kim, Hwi Jun ^f   Yong, Dongeun ^a   Chong, Yunsop ^a   Kim, Jae Seok ^g   Kim, Sunjoo ^h   Ryoo, Namhee ⁱ   Jeong, Seok Hoon ^j   Kim, Mun Yeun ^k   Ha, Gyoung Yim ^l   Chang, Chulhun L ^m   Park, Ki Hyung ⁿ   Kim, Mi Na ^o   Kim, Myungshin ^p   Kim, Jeong Ho ^q   Jeong, Joseph ^r   Ilong, Seok Il ^s   Cho, Soung Eun ^t   Kim, Jin Ju ^u   Lee, Hye Soo ^v   Jang, Sook Jin ^w   Park, Ae Ja ^x   Cha, Young Joo ^y   Shin, Dong Hoon ^z   Koo, Sun Hoe ^aa   Lee, Myung Hee ^ab   Song, Wonkeun ^g   Choi, Tae Yeal ^ac   Kim, Eui Chong ^ad   Kang, Jung Oak ^ac   Park, Yeon Joon ^ae   Shin, Jong Hee ^af   Hong, Seong Geun ^ag   Kim, Young Ah ^ah   Lee, Hee Joo ^ai   Cho, Dong Hee ^aj   Lim, Hwan Sub ^ak   Lee, Miae ^t   Shin, Hee Bong ^f   Kim, Young Ree ^al   Lee, Seung Ok ^am   Lee, Sung Hee ^an   Lee, Seong Gyu ^ao   more..

^a Yonsei University College of Medicine   (South Korea)

^b Wallace Memorial Baptist Hospital   (South Korea)

^c Wonkwang University Hospital   (South Korea)

^d Ajou University Medical Center   (South Korea)

^e Wonju Severance Christian Hospital   (South Korea)

^f Soonchunhyang University College of Medicine   (South Korea)

^g Hallym University College of Medicine   (South Korea)

^h Gyeongsang National University   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Kosin University   (South Korea)

^k Dankook University   (South Korea)

^l Dongguk University Gyeongju Hospital   (South Korea)

^m Pusan National University School of Medicine   (South Korea)

ⁿ Busan Medical Center   (South Korea)

^o Asan Medical Center   (South Korea)

^p The Catholic University of Korea   (South Korea)

^q Yonsei University College of Medicine   (South Korea)

^r Ulsan University College of Medicine   (South Korea)

^s Korea Animal Cancer Center   (South Korea)

^t Mokdong Hospital   (South Korea)

^u Inha University Hospital   (South Korea)

^v Chonbuk National University Medical School   (South Korea)

^w Chosun University   (South Korea)

^x Chung Ang University   (South Korea)

^y Yangsan Neuropsychiatric Hospital   (South Korea)

^z Hallym University   (South Korea)

^aa Chungnam National University College of Medicine   (South Korea)

^ab Korea Veterans Hospital   (South Korea)

^ac Hanyang University   (South Korea)

^ad Seoul National University College of Medicine   (South Korea)

^ae The Catholic University of Korea   (South Korea)

^af Chonnam National University Medical School   (South Korea)

^ag CHA University   (South Korea)

^ah National Health Insurance Corporation   (South Korea)

^ai Kyung Hee University College of Medicine   (South Korea)

^aj Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^ak Kwandong University Myunggi Hospital   (South Korea)

^al Jeju National University   (South Korea)

^am Seoul Medical Science Institute   (South Korea)

^an Cheju Hanmaeum Hospital   (South Korea)

^ao Bundang Jesaeng Hospital   (South Korea)

more..

Author keywords

Antimicrobial resistance surveillance; Ceftazidime resistance; Imipenem resistance; Korea

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HOSPITAL; KLEBSIELLA PNEUMONIAE; KOREA; LABORATORY; NONHUMAN; ORDO; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GAMMAPROTEOBACTERIA; HOSPITALS; IMIPENEM; KLEBSIELLA PNEUMONIAE; KOREA; LABORATORIES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 33750705251     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.5.634     Document Type: Article

References (48)

1. Morris AK, Masterton RG. Antibiotic resistance surveillance: action for international studies. J Antimicrob Chemother 2002;49:7-10.
2. Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance-what, how and whither? Clin Microbiol Infect 2001;7: 316-25.
3. Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, et al. Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 2003;9:1089-95.
4. Felmingham D, White AR, Jacobs MR, Appelbaum PC, Poupard J, Miller LA, et al. The Alexander Project: the benefit from a decade of surveillance. J Antimicrob Chemother 2005;56 (Suppl 2):ii3-ii21.
5. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004;10:349-83.
6. Chong Y, Lee K, Park YJ, Jeon DS, Lee MH, Kim MY, et al. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997. Yonsei Med J 1998;39: 569-77.
7. Lee K, Park KH, Jeong SH, Lim HS, Shin JH, Yong D, et al. Further increase of vancomycin-resistarit Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Yonsei Med J 2006;47:43-54.
8. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y, et al. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003;9:868-71.
9. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, et al. Prevalence of plasmid-mediated AmpC β-Lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006;12:44-9.
10. Gniadkowski M. Evolution and epidemiology of extended-spectrum β-lactamases, (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 2001;7: 597-608.
11. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268-74.
12. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306-25.
13. National Committee for Clinical Laboratory Standards. Analysis and presentation of cumulative antimicrobial susceptibility test data. Approved guideline M39-A. Wayne, PA: NCCLS; 2002.
14. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, et al. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 2002;8:697-701.
15. Stelling JM, O'Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis 1997; 24 Suppl 1:157-68.
16. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 1999;29:259-63.
17. National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing: fourteenth informational supplement. Wayne, PA: NCCLS; 2004.
18. Yasunaka K, Kono K. Epidemiological study of methicillin-resistant Staphylococcus aureus at Fukuoka University Hospital. Microb Drug Resist 1999;5:207-13.
19. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627-34.
20. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Strepfococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 2004;48:2101-7.
21. Mera RM, Miller LA, Daniels JJ, Weil JG, White AR. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 2005;51: 195-200.
22. Hunter PA, Reeves DS. The current status of surveillance of resistance to antimicrobial agents: report on a meeting. J Antimicrob Chemother 2002;49:17-23.
23. Zapantis A, Lacy MK, Horvat RT, Grauer D, Barnes BJ, O'Neal B, et al. Nationwide antibiogram analysis using NCCLS M39-A guidelines. J Clin Microbiol 2005;43: 2629-34.
24. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005;43: 462-3.
25. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001;39: 3747-9.
26. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang CH, Jeon GJ, et al. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004;42:2902-6.
27. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005;56:698-702.
28. Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, et al. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005; 52:323-9.
29. Goossens H, Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum (-lactamase-and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn Microbiol Infect Dis 2005;53:257-64.
30. Song W, Kim JS, Kim MN, Kim EC, Park YJ, Yong D, et al. Occurrence and genotypic distribution of plasmid-mediated AmpC β-lactamase-producing Eshcherichia coli and Klebsiella pneumoniae in Korea. Korean J Lab Med 2002;22:410-6.
31. Yong D, Lim Y, Song W, Choi YS, Park DY, Lee H, et al. Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producitig Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Diagn Microbiol Infect Dis 2005;53:65-70.
32. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
33. Bidet P, Burghoffer B, Gautier V, Brahimi N, Mariani-Kurkdjian P, El-Ghoneimi A, et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother 2005;49:3562-5.
34. Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother 2003;51:397-400.
35. Lee HK, Park YJ, Kim JY, Chang E, Cho SG, Chae HS, et al. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn Microbiol Infect Dis 2005;52:331-6.
36. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 2004;48:1586-92.
37. Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, Porath A, et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 2003;54:32-8.
38. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol 2000;3:489-95.
39. Kim IS, Oh WI, Song JH, Lee NY. Screening and identification of metallo-β-lactamase gene in clinical isolates of imipenem-resistant Pseudomonas aeruginosa. Korean J Lab Med 2004;24:177-82.
40. Kim IS, Lee NY, Ki CS, Oh WS, Peck KR, Song JH. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-β-lactamase producers in a Korean hospital. Microb Drug Resist 2005;11:355-9.
41. VIM-2-containing class 1 integron. Diagn Microbiol Infect Dis 2005;53:215-20.
42. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 2005; 43:2241-5
43. Reis AO, Luz DAM, Tognim MCB, Sader HS, Gales AC. Polymyxin-resistant Acinetobacter spp. isolates; what is next? Emerg Infect Dis 2003;9:1025-7.
44. Hooper DC. The future of the quinolones. APUA Newsletter 2001;19:1-5.
45. Park MS, Kang YH, Lee SJ, Song CY, Lee BK. Characteristics of epidemic multidrugresistant Salmonella enterica serovar Typhimurium DT104 strains first isolated in Korea. Korean J Infect Dis 2002;34:1-8.
46. Hasegawa K, Chiba N, Kobayashi R, Murayama Y, Iwata S, Sunakawa K, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004;48: 1509-14.
47. Lauderdale TL, McDonald LC, Shiau YR, Chen PC, Wang HY, Lai JF, et al. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis 2004; 48:211-9.
48. Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, Ernst EJ, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004;38:78-85.